Jefferies Reaffirms Their Buy Rating on Mankind Pharma Ltd. (MANKIND)

Jefferies analyst Alok Dalal maintained a Buy rating on Mankind Pharma Ltd. (MANKIND – Research Report) on May 23 and set a price target of INR2,870.00. The company's shares closed last Friday at INR2,425.00.
Confident Investing Starts Here:
According to TipRanks, Dalal is ranked #4967 out of 9536 analysts.
In addition to Jefferies, Mankind Pharma Ltd. also received a Buy from J.P. Morgan's Bansi Desai in a report issued on May 21. However, on the same day, Bank of America Securities maintained a Sell rating on Mankind Pharma Ltd. (NSE: MANKIND).

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

Business Wire

an hour ago

• Business Wire

Marin Software Incorporated Receives Nasdaq Notification Regarding Delisting From Nasdaq

SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Marin Software Incorporated (NASDAQ: MRIN) ('Marin,' 'we,' 'our,' or the 'Company'), a provider of digital marketing software for performance-driven advertisers and agencies, announces that, on June 17, 2025, the Company received a notice (the 'Notice') from the Listing Qualifications Department of the Nasdaq Stock Market LLC ('Nasdaq') stating that Nasdaq had determined that the Company did not provide a definitive plan evidencing its ability to achieve compliance with the Nasdaq Listing Rule 5250(c)(1) (the 'Listing Rule'), which requires listed companies to timely file all required periodic reports with the Securities and Exchange Commission (the 'SEC'). The Company had previously submitted a letter to Nasdaq requesting an exception to extend the Company's listing on Nasdaq for 180 days, until October 13, 2025. As a result of Nasdaq's determination, the Notice states that (i) the Company's request for continued listing on Nasdaq was denied; (ii) the Company's securities will be delisted from Nasdaq; (ii) trading of the Company's common stock will be suspended at the opening of business on June 26, 2025; and (iii) a Form 25-NSE will be filed with the SEC, which will remove the Company's securities from listing and registration on Nasdaq, unless the Company appeals these determinations. The Notice further states that the Company continues to be delinquent in the timely filing of the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2024, and its Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2025, as previously communicated by Nasdaq on April 16, 2025 and May 21, 2025, respectively. The Company does not expect to appeal Nasdaq's determinations and expects Nasdaq to file a Form 25-NSE (Notification of Removal from Listing) with the SEC to remove the Company's common stock from listing and registration on Nasdaq. Further, the Company does not currently intend to apply for its common stock to be traded on any of the markets operated by the OTC Markets Group Inc. due to the associated costs and in light of both the previously announced potential transaction the Company is currently exploring whereby a private equity firm would acquire substantially all of the assets of the Company, which may be through a voluntary reorganization transaction (the 'Potential Transaction'), as well as the voluntary dissolution and liquidation of the Company (the 'Dissolution') that was previously approved by the Company's stockholders. There can be no assurance that the Potential Transaction will be entered into or ultimately be successful, and the Company may abandon pursuing the Potential Transaction and instead pursue the Dissolution as previously described in the Company's Definitive Proxy Statement on Schedule 14A filed with the SEC on May 7, 2025 (the 'Proxy Statement'). For additional information regarding the Nasdaq notification and related terms, please see the Current Report on Form 8-K that the Company filed with the SEC today, which is available at Forward Looking Statements This press release contains 'forward-looking statements' within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (which Sections were adopted as part of the Private Securities Litigation Reform Act of 1995). Statements preceded by, followed by or that otherwise include the words 'believe,' 'anticipate,' 'estimate,' 'expect,' 'intend,' 'plan,' 'project,' 'prospects,' 'outlook,' and similar words or expressions, or future or conditional verbs such as 'will,' 'should,' 'would,' 'may,' and 'could' are generally forward-looking in nature and not historical facts. These forward-looking statements involve known and unknown risks, uncertainties and other factors. Marin disclaims any intention to, and undertakes no obligation to, revise any forward-looking statements, whether as a result of new information, a future event, or otherwise, except as required by applicable law. Actual results may differ from those indicated by such forward-looking statements the risks described under 'Risk Factors' in the Company's Quarterly Report on Form 10-Q filed with the SEC on November 12, 2024, the Proxy Statement under the heading 'Risk Factors to be Considered by Stockholders in Deciding Whether to Approve the Plan of Dissolution,' and the Company's future reports to be filed with the SEC. The forward-looking statements in this press release are based on information available to Marin as of the date hereof. The Company disclaims any obligation to update any forward-looking statements, except as required by law.

Yahoo

7 hours ago

• Yahoo

CyberArk's (CYBR) Price Target Raised to $480 at Jefferies

CyberArk Software Ltd. (NASDAQ:CYBR) is one of the 11 must-buy AI stocks analysts are betting on. On June 16, Jefferies reiterated its Buy rating on the stock and increased the price target to $480 from $430. The adjustment comes as the research firm remains confident about the company's strong positioning in the cyber-attacks market. Den Rise/ According to Jefferies, CyberArk Software has outperformed the overall market with a 16% yearly gain. The impressive run is supported by the company's 35.12% revenue growth and 77.91% gross profit margin, affirming growth. Jefferies expects the company to register significant growth in its annual recurring revenue through new Privileged Access Management (PAM) customers, maintenance conversions, and cross-selling opportunities. The firm also expects the company to achieve free cash flow margins of over 27%. CyberArk Software Ltd. (NASDAQ:CYBR) is a software company specializing in cybersecurity, focusing on Identity Security and Privileged Access Management (PAM). Its solutions help organizations protect their valuable assets by securing access to human and machine identities across various environments. It uses Artificial Intelligence (AI) in its Identity Security Platform to enhance security, efficiency, and user experience. While we acknowledge the potential of CYBR as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 12 Best Healthcare Stocks to Buy Now and 10 Stocks Analysts Are Upgrading Today. Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Business Insider

9 hours ago

• Business Insider

Bernstein Keeps Their Sell Rating on A.P. Moeller Maersk A/S (0O77)

Bernstein analyst Alex Irving maintained a Sell rating on A.P. Moeller Maersk A/S (0O77 – Research Report) yesterday and set a price target of DKK9,350.00. The company's shares closed yesterday at DKK11,945.00. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter According to TipRanks, Irving is a 4-star analyst with an average return of 9.2% and a 59.07% success rate. Irving covers the Industrials sector, focusing on stocks such as Deutsche Lufthansa, DHL Group, and International Consolidated Airlines. The word on The Street in general, suggests a Moderate Sell analyst consensus rating for A.P. Moeller Maersk A/S with a DKK10,900.00 average price target, which is a -8.75% downside from current levels. In a report released on June 13, Kepler Capital also maintained a Sell rating on the stock with a DKK9,250.00 price target. The company has a one-year high of DKK13,720.00 and a one-year low of DKK8,730.00. Currently, A.P. Moeller Maersk A/S has an average volume of 776.